Literature DB >> 28008821

Cooperative enhancement of translation by two adjacent microRNA-122/Argonaute 2 complexes binding to the 5' untranslated region of hepatitis C virus RNA.

Anika Nieder-Röhrmann1, Nadia Dünnes1, Gesche K Gerresheim1, Lyudmila A Shalamova1, Andreas Herchenröther1, Michael Niepmann1.   

Abstract

The liver-specific microRNA-122 (miR-122) binds to two conserved binding sites in the 5' UTR of hepatitis C virus (HCV) RNA. This binding was reported to enhance HCV RNA replication, translation and stability. We have analysed binding of miR-122/Argonaute 2 (Ago2) complexes to these sites using anti-Ago2 co-immunoprecipitation of radioactively labelled HCV RNAs along with ectopic miR-122 in HeLa cells. Our results show that the miR-122 target sites can be addressed separately. When both target sites were addressed simultaneously, we observed a synergistic binding of both miR/Ago2 complexes. Consistently, simultaneous binding of both miR-122/Ago2 complexes results in cooperative translation stimulation. In the binding assays as well as in the translation assays, binding site 1 has a stronger effect than binding site 2. We also analysed the overall RNA stability as well as the 5' end integrity of these HCV RNAs in the presence of miR-122. Surprisingly, using short HCV reporter RNAs, we did not find effects of miR-122 binding on overall RNA stability or 5' end integrity over up to 36 h. In contrast, using full-length HCV genomes that are incapable of replication, we found a positive influence of miR-122 on RNA stability, indicating that features of the full-length HCV genome that do not reside in the 5' and 3' UTRs may render HCV RNA genome stability miR-122 dependent.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28008821     DOI: 10.1099/jgv.0.000697

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

1.  miR-122 and Ago interactions with the HCV genome alter the structure of the viral 5' terminus.

Authors:  Jasmin Chahal; Luca F R Gebert; Hin Hark Gan; Edna Camacho; Kristin C Gunsalus; Ian J MacRae; Selena M Sagan
Journal:  Nucleic Acids Res       Date:  2019-06-04       Impact factor: 16.971

Review 2.  Signals Involved in Regulation of Hepatitis C Virus RNA Genome Translation and Replication.

Authors:  Michael Niepmann; Lyudmila A Shalamova; Gesche K Gerresheim; Oliver Rossbach
Journal:  Front Microbiol       Date:  2018-03-12       Impact factor: 5.640

3.  MiR-205-5p and miR-342-3p cooperate in the repression of the E2F1 transcription factor in the context of anticancer chemotherapy resistance.

Authors:  Xin Lai; Shailendra K Gupta; Ulf Schmitz; Stephan Marquardt; Susanne Knoll; Alf Spitschak; Olaf Wolkenhauer; Brigitte M Pützer; Julio Vera
Journal:  Theranostics       Date:  2018-01-01       Impact factor: 11.556

4.  TNRC6 proteins modulate hepatitis C virus replication by spatially regulating the binding of miR-122/Ago2 complexes to viral RNA.

Authors:  You Li; Li Wang; Efraín E Rivera-Serrano; Xian Chen; Stanley M Lemon
Journal:  Nucleic Acids Res       Date:  2019-07-09       Impact factor: 16.971

5.  What goes around comes around: Artificial circular RNAs bypass cellular antiviral responses.

Authors:  Janina Breuer; Patrick Barth; Yannic Noe; Lyudmila Shalamova; Alexander Goesmann; Friedemann Weber; Oliver Rossbach
Journal:  Mol Ther Nucleic Acids       Date:  2022-04-27       Impact factor: 10.183

6.  Functional sequestration of microRNA-122 from Hepatitis C Virus by circular RNA sponges.

Authors:  Isabelle Jost; Lyudmila A Shalamova; Gesche K Gerresheim; Michael Niepmann; Albrecht Bindereif; Oliver Rossbach
Journal:  RNA Biol       Date:  2018-02-28       Impact factor: 4.652

Review 7.  Hepatitis C Virus Translation Regulation.

Authors:  Michael Niepmann; Gesche K Gerresheim
Journal:  Int J Mol Sci       Date:  2020-03-27       Impact factor: 5.923

Review 8.  Hepatitis C Virus Downregulates Core Subunits of Oxidative Phosphorylation, Reminiscent of the Warburg Effect in Cancer Cells.

Authors:  Gesche K Gerresheim; Elke Roeb; Audrey M Michel; Michael Niepmann
Journal:  Cells       Date:  2019-11-08       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.